About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,039 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,039 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3401-3420 of 8,039 trials

Active not recruitingProspective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR MutationsThis is an observational multicenter study.NCT05103605·Abbeville and 45 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

UnknownAssessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFRThis study aimed to evaluate the safety and preliminary efficacy of YK-029A, a novel third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in treated…NCT05767866·Hefei, Anhui and 34 others

UnknownRBN-2397 in Combination With Pembrolizumab in Patients With SCCLRBN-2397 inhibits PARP7, an enzyme that is switched on by cancer stresses, such as the toxins in cigarette smoke.NCT05127590·Newark, Delaware and 18 others

Active not recruitingEfficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)This is a phase II, non-comparative, randomized study assessing combination of Tedopi with docetaxel or with nivolumab in NSCLC patients failing after first- line…NCT04884282·Avignon and 22 others

RecruitingThe Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)This is a first-in-human, single-arm, open-label, dose escalation prospective phase I clinical study to evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Alone in…NCT06861543·Beijing, Beijing Municipality

UnknownAlmonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene MutationThis is a multicenter, randomized, controlled, phase III study.NCT04500717·Beijing and 4 others

CompletedA Study of DKN-01 in Multiple Myeloma or Advanced Solid TumorsThe purpose of this trial is to characterize the safety and toxicity of DKN-01 by determining a maximum-tolerated dose and associated dose limiting toxicity.NCT01457417·Scottsdale, Arizona and 7 others

CompletedISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003989·Innsbruck and 26 others

TerminatedA Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804This study will enroll patients who are planned to undergo surgical removal of their tumor.NCT00971191·Birmingham, Alabama and 2 others

WithdrawnSRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung CancerThis trial is a randomized, 2-arm, phase II study to determine the effect, if any, of the timing of stereotactic radiosurgery (SRS) relative to immune checkpoint inhibitor (IO)…NCT04650490·Durham, North Carolina

CompletedSRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)This was a multi-center, open-label, Phase 1, first-in-human (FIH), dose-escalation, and dose expansion study to evaluate the safety, tolerability, pharmacokinetics (PK)…NCT04291079·Fullerton, California and 21 others

CompletedNeoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLCThis is a research study to test the effectiveness of nab-paclitaxel + carboplatin + MPDL3280A for treatment of non-small-cell lung carcinoma (NSCLC), which is a type of lung…NCT02716038·Boston, Massachusetts and 2 others

CompletedHypofraction Radiotherapy for Locally Advanced Non-small Cell Lung CancerDefinitive concurrent chemoradiotherapy followed by durvalumab (Pacific protocol) has been the standard modality for stage III locally advanced non-small cell lung cancer.NCT05269485·Hefei, Anhui

TerminatedSimilar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)NSCLC is the most common type of lung cancer. Metastatic cancers are cancers that start to spread to other parts of the body.NCT06643117·Batumi and 12 others

CompletedSuramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerThis randomized phase I trial is studying the side effects and best dose of suramin when given together with either docetaxel or gemcitabine in treating patients with stage IIIB…NCT00066768·Columbus, Ohio

UnknownHigh Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerTo assess the efficacy and feasibility of high-dose intensity-modulated radiotherapy with concurrent weekly paclitaxel and cisplatin for patients with locoregionally advanced…NCT03598517·Shanghai, Shanghai Municipality

CompletedPhase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based ChemotherapyThis is a randomized, positive-controlled, open-label, international multicenter, Phase 3 clinical study to compare the efficacy and safety of pyrotinib versus docetaxel in…NCT04447118·Orange, California and 101 others

CompletedIspinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerThis study was designed to determine how effective and safe Ispinesib is in treating locally advanced or metastatic Non-small Cell Lung cancer in patients who have received a…NCT00085813·Scottsdale, Arizona and 10 others

CompletedDenosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)Bone metastases are common in Non-Small Cell Lung Cancer (NSCLC). They most often occur during disease progression.NCT03669523·Aix-en-Provence and 26 others

UnknownComplete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is ConsideredRationale: Accurate staging of lung cancer is important because it directs treatment and determines prognosis.NCT02997449·Amsterdam and 3 others

PreviousPage 171 of 402Next